Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Influence of carvedilol on blood glucose and glycohaemoglobin A1 in non-insulin-dependent diabetics.

Ehmer B, van der Does R, Rudorf J.

Drugs. 1988;36 Suppl 6:136-40.

PMID:
2908300
2.

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

JAMA. 2004 Nov 10;292(18):2227-36.

PMID:
15536109
3.

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

J Cardiometab Syndr. 2008 Fall;3(4):211-7. doi: 10.1111/j.1559-4572.2008.00017.x.

4.

Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.

Bell DS, Bakris GL, McGill JB.

Diabetes Obes Metab. 2009 Mar;11(3):234-8. doi: 10.1111/j.1463-1326.2008.00927.x. Epub 2008 Jun 17.

PMID:
18564334
5.

Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.

Albergati F, Paternó E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L.

J Cardiovasc Pharmacol. 1992;19 Suppl 1:S86-9.

PMID:
1378156
6.

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.

Ann Intern Med. 1997 Jun 15;126(12):955-9.

PMID:
9182472
7.

Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.

Ruilope LM.

Am J Hypertens. 1994 Feb;7(2):129-36. Erratum in: Am J Hypertens 1994 Apr;7(4 Pt 1):379.

PMID:
7910028
8.

Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.

McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D.

Drugs. 1988;36 Suppl 6:82-91.

PMID:
2908306
9.

Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.

Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.

Drugs R D. 2011;11(2):171-90. doi: 10.2165/11592450-000000000-00000.

10.

Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin A1 in noninsulin-dependent diabetics.

Janka HU, Ziegler AG, Disselhoff G, Mehnert H.

J Cardiovasc Pharmacol. 1986;8 Suppl 11:S96-9.

PMID:
2439808
11.

Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.

Widmann L, van der Does R, Hörrmann M, Machwirth M.

Eur J Clin Pharmacol. 1990;38 Suppl 2:S143-6.

PMID:
1974505
12.

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.

Wong GW, Laugerotte A, Wright JM.

Cochrane Database Syst Rev. 2015 Aug 26;(8):CD007449. doi: 10.1002/14651858.CD007449.pub2. Review.

PMID:
26306578
13.

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.

Ollivier JP, Durier P, Bussiere JL, Gayet JL.

Eur J Clin Pharmacol. 1990;38 Suppl 2:S164-6.

PMID:
1974509
14.

Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.

Weber K, Bohmeke T, van der Does R, Taylor SH.

Cardiovasc Drugs Ther. 1996 May;10(2):113-7.

PMID:
8842502
15.

Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.

J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9.

16.
17.

Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.

Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F.

Diabetes Care. 1998 Apr;21(4):631-6.

PMID:
9571355
18.

Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.

Franz IW, Agrawal B, Wiewel D, Ketelhut R.

Clin Investig. 1992;70 Suppl 1:S53-7.

PMID:
1350485
19.

The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.

Ozbilen S, Eren MA, Turan MN, Sabuncu T.

Endocr Res. 2012;37(3):117-23. doi: 10.3109/07435800.2011.643436. Epub 2012 May 9.

PMID:
22571552

Supplemental Content

Support Center